Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accounts Payables: 2020-2025

Historic Accounts Payables for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $5.5 million.

  • iSpecimen's Accounts Payables rose 8.08% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 8.08%. This contributed to the annual value of $4.2 million for FY2024, which is 6.93% up from last year.
  • As of Q3 2025, iSpecimen's Accounts Payables stood at $5.5 million, which was up 10.63% from $5.0 million recorded in Q2 2025.
  • iSpecimen's 5-year Accounts Payables high stood at $5.5 million for Q2 2024, and its period low was $832,678 during Q4 2021.
  • Over the past 3 years, iSpecimen's median Accounts Payables value was $4.6 million (recorded in 2025), while the average stood at $4.4 million.
  • Over the last 5 years, iSpecimen's Accounts Payables had its largest YoY gain of 195.32% in 2022, and its largest YoY loss of 79.13% in 2022.
  • Over the past 5 years, iSpecimen's Accounts Payables (Quarterly) stood at $832,678 in 2021, then spiked by 195.32% to $2.5 million in 2022, then spiked by 59.63% to $3.9 million in 2023, then grew by 6.93% to $4.2 million in 2024, then climbed by 8.08% to $5.5 million in 2025.
  • Its Accounts Payables was $5.5 million in Q3 2025, compared to $5.0 million in Q2 2025 and $4.6 million in Q1 2025.